Arriving in Rome for the first time is like being dropped into a sprawling open-air labyrinth where every path beckons. Where to start? What to prioritize? How to assure the best experiences in a ...
Biomarker results from the KGOG3056/NIRVANA-R trial: Maintenance niraparib plus bevacizumab in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.
Jhin is one of the satisfying ADCs in League of Legends. He has incredible animations and a unique kit that allows him to stand out from the rest of the ADC pool. That said, his peculiarity can be a ...
With three dynamic tracks covering discovery, preclinical, clinical, and CMC, plus exclusive seminar days on ADC fundamentals and Bispecific ADCs, this guide ensures you gain critical insights and ...
Whether you're exploring emerging trends, novel payloads, or streamlined manufacturing strategies, this guide ensures you stay ahead in the ever-evolving ADC landscape. Download your copy now and ...
NEWCASTLE, England--(BUSINESS WIRE)--Iksuda Therapeutics (Iksuda), the developer of class leading, clinically validated antibody drug conjugates (ADCs) today announces that it will present three ...
Miller Reynolds is a Journalist and Writer with a strong passion for gaming and writing news. Awarded the Excellence in Writing and Production Award while attending Loyalist College, Miller is ...
ArriVent Biopharma, a company that secures rights to drugs from emerging markets to develop them for Western markets, is adding to its pipeline with a Phase 1-ready drug candidate from China that has ...
As a creative individual, Jordan Tassiello has a track record of achievements in founding her own business and working with large companies on writing, editing, design, content creation and campaigns.
CDMO Samsung Biologics expanded its collaboration with LigaChem Biosciences (LCB) to provide antibody-drug conjugate (ADC) services. Samsung will support a series of LigaChem’s ADC programs at Samsung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results